Boor Kathryn Jean
SEC CIK 1761826 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Dir | 25.1K | — | $298.9K | 7 | 2022-06-02 | 2026-06-04 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 20:11 | 2026-06-04 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | A - Grant | — | +16.9K | 25.1K | +204% | — | |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | A - Grant | — | +2,383 | 8,263 | +41% | — |
| 2024-12-06 | 2024-12-05 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | S - Sale | $125.55 | -1,636 | 5,880 | -22% | -$205.4K | |
| 2024-03-11 | 2024-03-11 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | S - Sale | $122.93 | -761 | 7,516 | -9% | -$93.5K | |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | A - Grant | $0.00 | +1,846 | 8,277 | +29% | $0 |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | A - Grant | $0.00 | +1,523 | 6,431 | +31% | $0 |
| D | 2022-06-06 | 2022-06-02 | SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Dir | A - Grant | $0.00 | +4,908 | 4,908 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations